After adjusting for clinicopathologic variables, SELENBP1 expression (P = 0.006), N stage (P < 0.001), and T stage (P = 0.033) remained significantly correlated with cancer-related death in RCC (Table 4). This evidence concerns the gene SELENBP1 and cancer.